PARI Pharma
Pre-clinicalBringing new innovative inhalation therapies to market is a long and risky process. The interaction of drug and device involves a high degree of complexity where both technical and regulatory requirements must be met. Having this in mind, choosing the ideal nebulizer and device partner can make all the difference and reduce overall development risks.
Private Company
Funding information not available
About
Bringing new innovative inhalation therapies to market is a long and risky process. The interaction of drug and device involves a high degree of complexity where both technical and regulatory requirements must be met. Having this in mind, choosing the ideal nebulizer and device partner can make all the difference and reduce overall development risks.